132 related articles for article (PubMed ID: 29599195)
1. 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia.
Tkaczynski E; Arulselvan A; Tkaczynski J; Avery S; Xiao L; Torok-Storb B; Abrams K; Rao NV; Johnson G; Kennedy TP; Poncz M; Lambert MP
Blood Adv; 2018 Apr; 2(7):754-761. PubMed ID: 29599195
[TBL] [Abstract][Full Text] [Related]
2. The role of platelet factor 4 in radiation-induced thrombocytopenia.
Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
[TBL] [Abstract][Full Text] [Related]
3. Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH).
Joglekar MV; Quintana Diez PM; Marcus S; Qi R; Espinasse B; Wiesner MR; Pempe E; Liu J; Monroe DM; Arepally GM
Thromb Haemost; 2012 Apr; 107(4):717-25. PubMed ID: 22318669
[TBL] [Abstract][Full Text] [Related]
4. Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.
Lambert MP; Rauova L; Bailey M; Sola-Visner MC; Kowalska MA; Poncz M
Blood; 2007 Aug; 110(4):1153-60. PubMed ID: 17495129
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
Krauel K; Hackbarth C; Fürll B; Greinacher A
Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
[TBL] [Abstract][Full Text] [Related]
6. Intramedullary megakaryocytes internalize released platelet factor 4 and store it in alpha granules.
Lambert MP; Meng R; Xiao L; Harper DC; Marks MS; Kowalska MA; Poncz M
J Thromb Haemost; 2015 Oct; 13(10):1888-99. PubMed ID: 26256688
[TBL] [Abstract][Full Text] [Related]
7. Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes.
Lambert MP; Wang Y; Bdeir KH; Nguyen Y; Kowalska MA; Poncz M
Blood; 2009 Sep; 114(11):2290-8. PubMed ID: 19605848
[TBL] [Abstract][Full Text] [Related]
8. Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets.
Jouni R; Zöllner H; Khadour A; Wesche J; Grotevendt A; Brandt S; Delcea M; Krauel K; Schwertz H; Sachs UJ; Greinacher A; Bakchoul T
Thromb Haemost; 2016 Jan; 115(2):324-32. PubMed ID: 26423467
[TBL] [Abstract][Full Text] [Related]
9. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
[TBL] [Abstract][Full Text] [Related]
11. In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice.
Han ZC; Bellucci S; Bodevin E; Wan HY; Shen ZX; Caen JP
C R Acad Sci III; 1991; 313(12):553-8. PubMed ID: 1773360
[TBL] [Abstract][Full Text] [Related]
12. Absolute immature platelet counts in the setting of suspected heparin-induced thrombocytopenia may predict anti-PF4-heparin immunoassay testing results.
Chen W; Ha JP; Hong H; Maitta RW
Transfus Apher Sci; 2018 Aug; 57(4):507-511. PubMed ID: 29661682
[TBL] [Abstract][Full Text] [Related]
13. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
14. Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin.
Lebeurier I; Basara N; Aïdoudi S; Amiral J; Caen JP; Han ZC
Br J Haematol; 1996 Jan; 92(1):29-34. PubMed ID: 8562407
[TBL] [Abstract][Full Text] [Related]
15. New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells.
Schulze A; Jensch I; Krauel K; Alahmad A; Müller HP; Greinacher A; Hundt M
Thromb Res; 2014 Jul; 134(1):174-81. PubMed ID: 24816371
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit.
Pierce W; Mazur J; Greenberg C; Mueller J; Foster J; Lazarchick J
Ann Clin Lab Sci; 2013; 43(4):429-35. PubMed ID: 24247801
[TBL] [Abstract][Full Text] [Related]
17. Chemokine regulation of human megakaryocytopoiesis.
Gewirtz AM; Zhang J; Ratajczak J; Ratajczak M; Park KS; Li C; Yan Z; Poncz M
Blood; 1995 Oct; 86(7):2559-67. PubMed ID: 7670101
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis.
Wang Q; You T; Fan H; Wang Y; Chu T; Poncz M; Zhu L
Platelets; 2017 Jan; 28(1):82-89. PubMed ID: 27534900
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
